Investors Overview

Investors Overview

Our Mission

BD is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care.

Learn more about BD

News Releases

08/10/2020

Summary Toggle BD and BD Foundation commit $7.8 million to helping community health centers expand innovative care to patients

FRANKLIN LAKES, N.J. , Aug. 10, 2020 /PRNewswire/ -- BD (NYSE: BDX), a leading global medical technology company, together with the BD Foundation , its charitable affiliate, today committed $7.8 million in monetary grants and product donations over the next three years to support the continued

PDF Version
08/06/2020

Summary Toggle BD Announces Results For 2020 Third Fiscal Quarter; Provides Fiscal 2020 Guidance

- As reported, revenues of $3.855 billion decreased 11.4 percent - On a currency-neutral basis, revenues decreased 9.4 percent - As reported, diluted earnings per share of $0.97 decreased 35.8 percent - As adjusted, diluted earnings per share of $2.20 decreased 28.6 percent or 25.0 percent on

PDF Version 427.2 KB
08/03/2020

Summary Toggle BD releases FY 2019 Sustainability Report

FRANKLIN LAKES, N.J. , Aug. 3, 2020 /PRNewswire/ -- BD ( Becton, Dickinson and Company ) (NYSE: BDX), a leading global medical technology company, today issued its 2019 Sustainability Report, focusing on performance of the environmental, social and governance factors that support the company's

PDF Version
07/30/2020

Summary Toggle BD Announces $24 Million U.S. Government Investment to Support Scale Up of U.S. Manufacturing of COVID-19 Diagnosic Tests

Capital investments will enable U.S. manufacturing of 8 million BD Veritor™ brand SARS-CoV-2 tests per month FRANKLIN LAKES, N.J. , July 30, 2020 /PRNewswire/ -- BD ( Becton, Dickinson and Company ) (NYSE: BDX), a leading global medical technology company, today announced a $24 million investment

PDF Version
07/27/2020

Summary Toggle BD Board Declares Dividends

FRANKLIN LAKES, N.J. , July 27, 2020 /PRNewswire/ -- The Board of Directors of BD ( Becton, Dickinson and Company ) (NYSE: BDX) has declared a quarterly dividend of $0.79 per common share, payable on September 30, 2020 to holders of record on September 9, 2020 . The indicated annual dividend rate

PDF Version
07/22/2020

Summary Toggle BD receives FDA Approval for HPV Test with Extended Genotyping Capabilities

BD Onclarity™ HPV Assay is the only FDA-approved HPV assay to individually identify and report genotypes beyond 16, 18 and 45 FRANKLIN LAKES, N.J. , July 22, 2020 /PRNewswire/ -- BD ( Becton, Dickinson and Company ) (NYSE: BDX), a leading global medical technology company, today announced that it

PDF Version